Ardent Health, Inc. (NYSE:ARDT – Get Free Report) has been given an average rating of “Hold” by the fourteen brokerages that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, five have given a hold recommendation and seven have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued a report on the stock in the last year is $14.2083.
Several analysts have recently issued reports on the stock. UBS Group lifted their target price on shares of Ardent Health from $13.00 to $13.50 and gave the company a “buy” rating in a research report on Thursday, May 7th. Leerink Partners dropped their target price on shares of Ardent Health from $16.00 to $15.00 and set an “outperform” rating on the stock in a research report on Friday, March 6th. Zacks Research upgraded shares of Ardent Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 25th. Wall Street Zen upgraded shares of Ardent Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 16th. Finally, Royal Bank Of Canada dropped their target price on shares of Ardent Health from $14.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, March 9th.
Get Our Latest Research Report on Ardent Health
Ardent Health Stock Up 0.7%
Ardent Health (NYSE:ARDT – Get Free Report) last announced its earnings results on Tuesday, May 5th. The company reported $0.28 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.18 by $0.10. Ardent Health had a net margin of 2.09% and a return on equity of 13.85%. The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.58 billion. Ardent Health has set its FY 2026 guidance at 0.900-1.270 EPS. On average, research analysts forecast that Ardent Health will post 1.12 EPS for the current year.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its holdings in Ardent Health by 1,177.7% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 2,862 shares of the company’s stock valued at $25,000 after purchasing an additional 2,638 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank acquired a new position in Ardent Health during the third quarter worth about $61,000. Monetary Solutions Ltd acquired a new position in Ardent Health during the fourth quarter worth about $79,000. New York State Common Retirement Fund boosted its position in Ardent Health by 121.4% during the second quarter. New York State Common Retirement Fund now owns 6,200 shares of the company’s stock worth $85,000 after acquiring an additional 3,400 shares during the last quarter. Finally, Abel Hall LLC acquired a new position in Ardent Health during the first quarter worth about $87,000.
Ardent Health Company Profile
Ardent Health, listed on the New York Stock Exchange under the ticker ARDT, is a healthcare delivery company focused on acquiring, developing and managing acute care hospitals and complementary outpatient facilities across the United States. The company’s integrated platform encompasses both inpatient and outpatient services, designed to provide end-to-end care solutions and address the full continuum of patient needs.
Through its network, Ardent Health operates general hospitals, emergency departments, ambulatory surgery centers, urgent care clinics, rehabilitation and post-acute care facilities.
See Also
- Five stocks we like better than Ardent Health
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
